Release of provisional recommendations for expert advisory committees

1 July 2025 - We’re improving our processes, so that people can understand the outcome of expert advice to PHARMAC earlier. ...

Read more →

EMA 2024 annual report is published

10 June 2025 - The EMA’s annual report 2024 published today gives insights into the Agency’s strategic priorities and contributions ...

Read more →

ICER publishes evidence report on treatment for secondary progressive multiple sclerosis

29 May 2025 - There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve ...

Read more →

Outcome statement - April 2025 DUSC meeting

16 May 2025 - The outcome statement from the April 2025 DUSC meeting is now available. ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 PBAC meeting

24 April 2025 - The Public Summary Documents (first-time decisions not to recommend and deferrals) from the December 2024 PBAC meeting ...

Read more →

Public Summary Documents – December 2024 PBAC meeting

11 April 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2024 PBAC ...

Read more →

ICER publishes evidence report on treatment for retinitis pigmentosa

26 March 2025 - There are significant uncertainties regarding long term efficacy and durability of sonpiretigene isteparvovec; ICER estimates that ...

Read more →

Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting

21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...

Read more →

DUSC utilisation analysis public release documents (October 2024)

14 March 2025 - The utilisation analysis public release documents from the October 2024 DUSC meeting are now available. ...

Read more →

Public Summary Documents – November 2024 PBAC meeting

7 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...

Read more →

ICER releases draft evidence report on treatment for advanced retinitis pigmentosa

6 February 2025 - Public comment period now open until 6 March 2025; requests to make oral comment during public ...

Read more →

ICER publishes evidence report on treatment for acute pain

5 February 2025 - Current evidence suggests that suzetrigine may provide a net health benefit when compared to no systemic ...

Read more →

Utilisation analysis of heart failure medicines listed on the PBS

20 December 2024 - At its September 2024 meeting, the PBAC considered a report presenting a utilisation analysis of PBS ...

Read more →

PBS Expenditure and Prescriptions Report (2023-24)

19 December 2024 - The PBS Expenditure and Prescriptions Report 1 July 2023 to 30 June 2024 is now available. ...

Read more →

Report on PBS/RPBS under co-payment prescriptions data (2023-24)

19 December 2024 - The Report on Under Co-payment Prescriptions Data (2023-24) is now available. ...

Read more →